PMH5 INFLUENCE OF PSYCHIATRIC COMORBIDITY AND POLYPHARMACY ON HOSPITALIZATION AND EXPENDITURES AMONG SECOND GENERATION ANTIPSYCHOTIC USERS WITH METABOLIC SYNDROME
Abstract
Authors
HK Yang L Simoni-Wastila CD Mullins E Onukwugha F Palumbo JM Noel